Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Asston Pharmaceuticals Ltd (NSE: APL), ISIN INE0SJX01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
APL last traded at ₹100.15 (-1.81%), with a 52-week range of ₹60.00 to ₹126.10 (as of 23 Sep 2026).
Shareholding as of Sep 2025: promoters 50.66%, FIIs 6.04%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 27/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.